November 16, 2026

Are you asking your patients about their cannabis use? Two new studies shine a light on patient safety concerns during procedures

By: Joe Paone
Share

Chances are that most days, numerous patients treated at your facility are marijuana consumers. The question is, do you know if they are? If so, how are they consuming it? How often? And how much are they consuming in terms of dosage?

While the great majority of these patients will experience no unique safety issues during their procedures, a growing amount of data shows that many of these patients, especially frequent cannabis users, could benefit from additional care and attention in the name of their surgical or procedural safety, particularly from their anesthesia providers and during preoperative assessments.

At the American Society of Anesthesiologists’ (ASA’s) ANESTHESIOLOGY 2026 conference last month, two study abstracts presented on the subject generated a lot of interest, and were promoted by ASA to media outlets. While not major studies, they provide compelling new data points for perioperative leaders to consider as they continue to provide surgeries and procedures to an ever-growing number of patients who consume cannabis.

The first, “Perioperative Anesthetic Complications Associated with Cannabis Use: A Systematic Review and Meta-Analysis,” describes a systematic review and meta-analysis to quantify associations between cannabis use and specific perioperative complications, particularly cardiac issues.

The second, “Not All Cannabis Is Equal: Inhaled Marijuana Increases Propofol Requirements for Endoscopy,” evaluated the association between cannabis use, its route of consumption, and propofol induction dose in patients undergoing gastrointestinal (GI) endoscopy.

We spoke with co-authors of each study to dive deeper into their findings.

Cardiac risks

The first study abstract opens with this statement: “Cannabis use among surgical patients has nearly tripled over the past decade, yet evidence regarding perioperative outcomes remains conflicting.” It notes that tetrahydrocannabinol (THC), the primary psychoactive cannabinoid found in the cannabis plant, “induces sympathetic activation, increases myocardial oxygen demand, and promotes platelet activation and endothelial dysfunction—mechanisms that may precipitate cardiovascular and cerebrovascular events in the perioperative setting.”

The authors searched the PubMed, Embase, Cochrane Library, and OpenEvidence databases for eligible studies that “enrolled adult surgical patients, defined cannabis exposure using validated diagnostic codes or structured interviews, reported quantitative outcome data for predefined perioperative complications, and included a non-cannabis-using comparator group.” They found just five eligible observational studies, with three studies comprising 44,312 patients (22,156 cannabis users and 22,156 non-users) included in quantitative synthesis.

Based on this limited evidence, they found that cannabis use was associated with “significantly increased risk of myocardial infarction and a reduced risk of venous thromboembolism,” while observing “no significant associations” for stroke, respiratory failure, acute kidney injury or all-cause mortality. The authors state that their findings “support current guideline recommendations for preoperative cannabis screening and heightened cardiovascular surveillance.”

Study co-author Rose Berkun, MD, FASA, associate professor with the Department of Anesthesiology at Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (N.Y.), told Periop Leader Network that recent research, including a 2025 study of millions of patients that she said found that chronic cannabis users have a six times greater chance of heart attack perioperatively, has placed growing focus on potential cardiac risks for cannabis users undergoing surgery.

Dr. Berkun’s study abstract conveyed the finding that perioperative risk of heart attack was 46% higher among cannabis users. She said, “There is more and more evidence that shows that perioperative cardiac risk factors are there, and they are much higher in chronic cannabis users,” whom she defines as patients who consume cannabis more than twice weekly. She added that two observational studies that were rejected for her study also showed higher incidence of stroke among chronic cannabis users. “Cannabis has detrimental effects on the brain,” she said. “It vasoconstricts blood vessels, and it vasoconstricts the heart. That’s part of the mechanism of why people will get heart attack; same thing with stroke.”

Rose Berkun, MD, FASA, Associate Professor, Department of Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo

Dr. Berkun, whose work generally involves sedation of plastic surgery patients in office-based environments, said that approximately 30% of her patients are chronic cannabis users, which “really affects anesthesia.” As a result, she not only counsels patients to halt cannabis use four weeks before surgery—she noted that not a single patient has presented for surgery with withdrawal symptoms—but also tests each patient for THC.

“The reason I test them is because when they’re THC-positive, it affects my overall anesthetic because my patients are not paralyzed,” she said. “Every patient that comes into my practice gets TIVA [total intravenous anesthesia], and they’re deeply anesthetized. All I have at my disposal are intravenous agents, and I can add nitrous. I’m worried about cardiac complications, but I’m also worried about other anesthetic effects where I need to totally adjust my anesthetic. They need a lot more and they need different types of anesthetic. It doesn’t affect them as much when they’re under general anesthesia, intubated and paralyzed; they’re not going to move, and if they need more pain meds they get more opioids, but the surgeon is not going to say, ‘My patient is moving.’”

Intraoperatively, Dr. Berkun takes special care with chronic cannabis users. “We have to be very careful and diligent with how we maintain their blood pressure, and with blood pressure fluctuations,” she said. “We don’t want it too high or too low. Usually, it should be no more than within 20% of their pre-op blood pressure. We also look at the EKG and specifically at arrhythmias because they can have fatal arrhythmias. They can have tachycardia. We need to be prepared for that, to keep it in the back of our mind that this can happen.”

Dr. Berkun said it’s not recommended to cancel or delay surgery if the patient consumed cannabis the day before, but if they consume it the day of, especially within two hours of the procedure, she postpones the procedure. Patients with comorbidities and pre-existing conditions who take very high doses of THC should be routed to hospitals for their surgeries, she added. “We have patients who are very honest with us—’I can’t stop it, and I am on a very high dose,’” she said. “Those patients absolutely have to be done in the hospital. They may require invasive monitors like arterial blood pressure that will give us second-by-second blood pressure instead of every three minutes. They may require EEG monitoring to make sure we know the level of anesthesia and keep it at a certain level.”

Preoperative assessments are crucial

Dr. Berkun emphasized that preoperative assessments and screenings should not only determine if the patient consumes cannabis, but how they consume it. She said that determining the mode of consumption is “very beneficial because smoking causes respiratory effects like bronchospasm and irritation of the airway.”

Another data point that should be part of the preoperative assessment, she said, is to determine the dosages of THC the patient consumes. “The problem with THC is that the cannabis that people use right now is very different from decades before,” said Dr. Berkun. “If you look at 20 or 30 years ago, the percent of THC was between 2% and 4%. Since then, the potency has been going up and up and up. My understanding is that some concentrates for vaping are 90% pure THC. A lot of what they consume is 30% to 40% THC, both in edibles and smoking, and because the risk factors and the effects and side effects are dose-dependent, that’s why we’re starting to see a lot of adverse effects. The higher the dose, the more effect and risk factors for arrhythmia and for heart attack.”

Dr. Berkun said most patients have no idea about the THC dosages they consume. As a result, she advocates for government regulation of recreational marijuana to make it more like medical marijuana, where dispensaries are required to list dosages and percentages of THC.

If you’re hesitant to dig too deeply with patients about their cannabis use, don’t be, said Dr. Berkun, who adds that her patients are appreciative when they learn of her safety concerns. “It has nothing to do with judgment,” she said. “We ask patients routinely whether they drink and how much because that affects anesthetic and their risk factors. Same thing with smoking, same thing with cannabis. It has to do with safety, because our goal is to keep the anesthetic as safe as possible.”

She didn’t always dig so deeply. Initially, it was another item on the preoperative questionnaire, with the note that cannabis users might require additional anesthesia. However, she found some patients were less than forthcoming about their use, and subsequently were found to be THC-positive. She believes some of her THC-positive patients aren’t even users themselves, but inhale it secondhand from users with whom they live. That led to the default THC testing and counseling.

Her advice to perioperative leaders: “It has to be standardized as part of the pre-op assessment—it has to be on the questionnaire, and it has to be asked orally. One of the questions on a pre-op assessment has to be ‘Do you use marijuana products? How much and how often?’ We’re not asking because we’re curious. We’re asking because we want to safely administer anesthetic. We need to educate our patients. They need to understand that it’s not without risk, and that the more they consume, the higher the risk.”

She added that anesthesiologists should alleviate patients’ hesitancy to discuss their use by making it clear that the information they provide is HIPAA protected. “It has to stay there in the chart,” she said. “It’s only for the anesthesiologist and the surgeon—that’s it. Nobody else. We document it in our anesthesia record. The nurses don’t have to document it, but even if they do, it stays there. It’s protected information.”

When asked how many of her cannabis-consuming patients are aware of the possible cardiac risks they face when undergoing surgery, she replied, “Almost none. That’s why we need to publicize this, spread the word, talk about it. We need to increase awareness—especially for us as anesthesiologists, that when patients come in, they have to let us know. People have to understand THC is a drug. Yes, it’s made from a plant, but so is heroin or opium. It’s not harmless.”

As for awareness among anesthesiologists, Dr. Berkun said practitioners worldwide have noticed over the last half-decade or so that they are seeing “more and more patients who use cannabis, and they’re much harder to anesthetize. Where we still need to increase awareness among anesthesiologists is about the risk factors that come in play. It’s not just that they’re harder to anesthetize, that they move and they need more opioids. It’s perioperative risk of heart attack and fatal arrhythmias that we need to be aware of. It’s very important to educate anesthesiologists at every site that they have a higher chance of these complications. Not everybody goes to conferences. There is more and more information coming out, and it’s readily accessible. Anesthesiologists need to be aware that they have to look for it.”

More study is required, said Dr. Berkun: “The more research we have, the better will be the guidelines. The studies have to be clinically relevant. It can’t be in mice. It can’t be on a muscle cell. It has to be in the patient population.”

Upper endoscopy and propofol requirements

The second study abstract described a retrospective review of hundreds of endoscopic procedures performed at a single facility—Jefferson Health’s outpatient Honickman Center in Philadelphia. Data collected included age, BMI, procedure type, cannabis use, route of consumption (none, inhalation, oral), and propofol induction dose. Two procedures were categorized: esophagogastroduodenoscopy (EGD) and colonoscopy, with the primary outcome being induction dose of propofol.

A total of 264 patients with complete cannabis route data were included; 217 were non-users, 38 inhaled cannabis, and nine consumed it orally. When the 47 cannabis users were analyzed as a single group, the study found no significant difference with non-users in terms of propofol dosage. However, when stratified by route, the finding was higher induction requirements among inhalation users undergoing EGD, with inhalation users requiring “substantially higher” propofol doses (192.8 mg) compared to non-users (151.4 mg).

The study abstract concludes that “propofol induction requirements vary by cannabis consumption route. Inhaled cannabis use is associated with increased induction dosing, particularly in patients undergoing EGD, while no significant differences were observed in colonoscopy. These findings highlight the importance of route-specific assessment of cannabis use during pre-procedural evaluation.”

Study co-author Basavana Goudra, MD, FRCA, FCARCSI, FASA, Medical Director, Outpatient GI Endoscopy Services with Thomas Jefferson University in Philadelphia, told Periop Leader Network that he noticed about a decade ago that marijuana users required more anesthesia. As the drug became increasingly legalized or decriminalized, and usage grew among the general population, he noticed more studies describing an increase in the propofol requirement for insertion of the laryngeal mask airway in marijuana users. He also noticed, however, that “both in my own personal anesthesia practice and talking with the nurse anesthetists I supervised, that not necessarily all patients who use marijuana require high doses of propofol. I noticed the increased use was more with the upper endoscopies,” whereas patients undergoing colonoscopies required more or less normal amounts of propofol. He decided to perform a study to confirm this anecdotal evidence.

Basavana Goudra, MD, FRCA, FCARCSI, FASA, Medical Director, Outpatient GI Endoscopy Services, Thomas Jefferson University

While he concedes that the study’s sample size is small and is “more of a pilot study,” he wasn’t surprised by the results: increases in propofol requirements were evident in upper endoscopy but not colonoscopy, and inhalation users required much higher increases than users who consume marijuana orally through things like edibles.

When he presented the study abstract to fellow anesthesiologists at the annual meeting, he said “they were kind of surprised because the general consensus of opinion is that usage of marijuana increases propofol requirements across the board. The finding that our study shows it was only for upper endoscopy procedures [and not colonoscopies] came as a surprise.

“As with tobacco smoking, marijuana smoking is an irritant to the respiratory tree, especially the upper airway,” said Dr. Goudra. “It’s well known and documented that it causes inflammation of your trachea and larynx, and that is responsible for increased propofol need in order to get the endoscope inserted into the esophagus.” He and other Jefferson providers noticed that many patients who inhale marijuana “appear to go to sleep as if normally, but when we try to insert the scope, they start coughing, so we end up injecting more propofol and finally we get them to sleep.” He described this increase in propofol requirement as “sometimes remarkable, sometimes even two to three times” what non-users require.

Like Dr. Berkun, Dr. Goudra calls for more detailed preoperative assessments on patients’ use of cannabis. “Instead of just asking about marijuana usage with a yes/no box, dig a bit deeper into the method they’re using, the amount they’re using, and when they last used it,” he said. “Also pay attention to the procedure that’s being performed, and be aware that, if they’re undergoing upper endoscopy, to anticipate increased propofol requirement and even warn the patient. Along with the increased propofol requirements, it can also cause laryngospasm, where the vocal cords can close up. Patients need to be warned about that as well, and the anesthesia provider should be aware of that too. At Jefferson, the nurse anesthetists are pretty aware what to expect if somebody is an inhalational marijuana user. I think other centers may not be aware of it, especially those which have small volume. Our volumes are pretty high, so we have a good idea what goes on.

“At Jefferson, the nurses document and the anesthesia attending who is consenting the patient document. So it is documented in the chart, but we know that many times patients may not tell the truth,” he said. “There is still some stigma attached in spite of decriminalization, and especially young people with their mothers sitting there may not like to tell. But it is important for people to be aware of it when they present for anesthesia instead of trying to hide it, which is understandable. It’s probably better to be more open and discuss their marijuana usage habits with the anesthesia provider.”

In his practice, if Dr. Goudra knows before a procedure that a patient has smoked or taken cannabis in the preceding one hour, “it increases the risk of myocardial infarction, having cardiac issues, or posing cardiac problems for us. I explain the reason for cancelation. Another thing, especially if they’re heavy users, is that there is some risk of gastroparesis or slowing of the stomach emptying, which can pose aspiration risk. These are the main things, especially with those coming for endoscopy anesthesia, which I’ll be watching just to make sure we don’t cause any harm to them.”

Dr. Goudra would like to see a larger study where patients are questioned more in-depth about their cannabis usage. “The last dose is especially important because the effects could be more dominant if the last time of inhalation was a few hours before the surgery or procedure,” he said. “They can also look at other procedures, like general surgeries requiring laryngeal mask airway. We can also look at similar procedures which can irritate the airway where patients are not paralyzed.”

He also is curious to see studies that examine differences in effect between “street” marijuana versus that acquired at a dispensary, as well as the effects of marijuana that is contaminated with other ingredients. “The lacing is so common,” he says. “We all know that.”

Join our community

Learn More
Video Spotlight
Live chat by BoldChat